secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2025-08-22T23:59:59+00:00
Accession:  0001641172-25-025238
Event type: earnings
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics Health Q2 2025 results: H1 pro forma revenue $18.65M, debt conversion strengthens balance sheet
--------------------------------------------------------------------------------

- Pro forma revenue for H1 2025 was $18.65M, up 2.2% from $18.25M in H1 2024.
- Converted $10.1M of debt into common stock equity (including $8.6M after June 30) to improve balance sheet flexibility.
- Completed operational integration of Wellgistics LLC and Wood Sage LLC, reduced SG&A, upgraded ERP system.
- Appointed UHY LLP, a PCAOB-registered auditor, which completed Q2 review; advancing SOC 2 certification.
- Expanding DTP programs in diabetes, weight loss, chronic pain; network includes 6,500+ pharmacies and 200 manufacturers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000164117225025238/0001641172-25-025238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000164117225025238/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-025238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer